November 2023
-
11.21.2023 Updates & Statements Antimicrobial Resistance Artificial Intelligence Medicines Wellness Listen Now: Award-Winning ‘Science Will Win’ Podcast Explores Antimicrobial Resistance -
11.16.2023 Updates & Statements Albert Bourla Business Diversity & Inclusion Leadership Pfizer CEO Albert Bourla Discusses Curing the Epidemic of Exclusion at APEC CEO Summit -
11.01.2023 Updates & Statements Albert Bourla Business Covid-19 Diversity & Inclusion Leadership Responsibility October Social Media Round-Up—Israel-Hamas War, COVID-19 Treatment News, and Pfizer Makes Forbes List
October 2023
-
10.30.2023 Updates & Statements Covid-19 Diseases & Conditions Government Pfizer's COVID-19 Oral Antiviral Treatment Transitioning from Government Distribution -
10.27.2023 Perspectives Covid-19 Diseases & Conditions Health Equity Influenza Partnerships Research Respiratory Syncytial Virus Vaccines The Power of Partnership in our Mission to Better Connect the Patient Health Journey -
10.17.2023 Events Diversity & Inclusion Pfizer Culture Responsibility Accelerating Equity Takes the Spotlight at Pfizer’s Global DEI Summit -
10.16.2023 Covid-19 Diseases & Conditions Influenza mRNA Research Respiratory Syncytial Virus Vaccines Easing the Healthcare Burden of the Seasonal Triple-demic and Pfizer’s Unwavering Commitment to Public Health -
10.06.2023 Updates & Statements Albert Bourla Covid-19 History Research Vaccines Nobel Prize Awarded to Scientists Responsible for mRNA Breakthrough -
10.04.2023 Updates & Statements Business Clinical Trials Diversity & Inclusion Leadership September Social Media Round-Up—DEI, CMO, and Rocky Mount Resumes
September 2023
-
09.29.2023 Events Diseases & Conditions Partnerships Patient Centricity Ulcerative Colitis Wellness Helping UC Patients to “Live Fully” with Sunny Anderson -
09.25.2023 Updates & Statements Responsibility Pfizer’s Rocky Mount Facility Restarts Production Amid First Phase of Post-Tornado Recovery Efforts -
09.22.2023 Perspectives Diseases & Conditions Diversity & Inclusion Health Equity Patient Centricity Rare Diseases Sickle Cell Disease An Open Letter in Support of Sickle Cell Disease Communities